Generation of KS-133 as a Novel Bicyclic Peptide with a Potent and Selective VIPR2 Antagonist Activity that Counteracts Cognitive Decline in a Mouse Model of Psychiatric Disorders
Kotaro Sakamoto(Ichimaru Pharcos (Japan)), Yukio Ago(Hiroshima University), S Asano(Hiroshima University), Tatsunori Miyaoka(The University of Osaka), Teruaki Masutani(Ichimaru Pharcos (Japan)), Kenji Ishimoto(Osaka University of Pharmaceutical Sciences), Nobumasa Hino(Osaka University of Pharmaceutical Sciences), Lu Chen(Zhengzhou University of Light Industry), Shinsaku Nakagawa(Osaka University of Pharmaceutical Sciences), Mei Yamada(The University of Osaka)
Cited by 16